REGENERON BEGINS FIRST CLINICAL TRIALS OF ANTI-VIRAL ANTIBODY COCKTAIL REGN-COV2 FOR THE TREATMENT AND PREVENTION OF COVID-19 \

?View original content:http://www.prnewswire.com/news-releases/regeneron-begins-first-clinical-trials-of-anti-viral-antibody-cocktail-regn-cov2-for-the-treatment-and-prevention-of-covid-19-301074103.html